117 related articles for article (PubMed ID: 17673463)
21. Low frequency of TEL/AML1 in adult acute lymphoblastic leukemia.
Kwong YL; Wong KF
Cancer Genet Cytogenet; 1997 Oct; 98(2):137-8. PubMed ID: 9332479
[TBL] [Abstract][Full Text] [Related]
22. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis.
Shurtleff SA; Buijs A; Behm FG; Rubnitz JE; Raimondi SC; Hancock ML; Chan GC; Pui CH; Grosveld G; Downing JR
Leukemia; 1995 Dec; 9(12):1985-9. PubMed ID: 8609706
[TBL] [Abstract][Full Text] [Related]
23. TEL/AML1 overcomes drug resistance through transcriptional repression of multidrug resistance-1 gene expression.
Asakura K; Uchida H; Miyachi H; Kobayashi H; Miyakawa Y; Nimer SD; Takahashi H; Ikeda Y; Kizaki M
Mol Cancer Res; 2004 Jun; 2(6):339-47. PubMed ID: 15235109
[TBL] [Abstract][Full Text] [Related]
24. The TEL-AML1 fusion accompanied by loss of the untranslocated TEL allele in B-precursor acute lymphoblastic leukaemia of childhood.
Kempski HM; Sturt NT
Leuk Lymphoma; 2000 Dec; 40(1-2):39-47. PubMed ID: 11426627
[TBL] [Abstract][Full Text] [Related]
25. Characterization of additional genetic events in childhood acute lymphoblastic leukemia with TEL/AML1 gene fusion: a molecular cytogenetics study.
Ma SK; Wan TS; Cheuk AT; Fung LF; Chan GC; Chan SY; Ha SY; Chan LC
Leukemia; 2001 Sep; 15(9):1442-7. PubMed ID: 11516105
[TBL] [Abstract][Full Text] [Related]
26. Three distinct domains in TEL-AML1 are required for transcriptional repression of the IL-3 promoter.
Uchida H; Downing JR; Miyazaki Y; Frank R; Zhang J; Nimer SD
Oncogene; 1999 Jan; 18(4):1015-22. PubMed ID: 10023677
[TBL] [Abstract][Full Text] [Related]
27. Lack of TEL-AML1 fusion transcript resulting from a cryptic t(12;21) in adult B lineage acute lymphoblastic leukemia in Taiwan.
Shih LY; Chou TB; Liang DC; Tzeng YS; Rubnitz JE; Downing JR; Pui CH
Leukemia; 1996 Sep; 10(9):1456-8. PubMed ID: 8751462
[TBL] [Abstract][Full Text] [Related]
28. TEL-AML1 fusion precedes differentiation to pre-B cells in childhood acute lymphoblastic leukemia.
Pine SR; Wiemels JL; Jayabose S; Sandoval C
Leuk Res; 2003 Feb; 27(2):155-64. PubMed ID: 12526921
[TBL] [Abstract][Full Text] [Related]
29. Correlation between cellular localization of TEL/AML1 fusion protein and repression of AML1-mediated transactivation of CR1 gene.
Rho JK; Kim JH; Yu J; Choe SY
Biochem Biophys Res Commun; 2002 Sep; 297(1):91-5. PubMed ID: 12220513
[TBL] [Abstract][Full Text] [Related]
30. ETV6/RUNX1 transcript is a target of RNA-binding protein IGF2BP1 in t(12;21)(p13;q22)-positive acute lymphoblastic leukemia.
Stoskus M; Vaitkeviciene G; Eidukaite A; Griskevicius L
Blood Cells Mol Dis; 2016 Mar; 57():30-4. PubMed ID: 26852652
[TBL] [Abstract][Full Text] [Related]
31. TEL/AML1-positive patients lacking TEL exon 5 resemble canonical TEL/AML1 cases.
Zaliova M; Meyer C; Cario G; Vaskova M; Marschalek R; Stary J; Zuna J; Trka J
Pediatr Blood Cancer; 2011 Feb; 56(2):217-25. PubMed ID: 21157892
[TBL] [Abstract][Full Text] [Related]
32. Cloning and sequencing of ETV6/RUNX1 (TEL/AML1) variant in acute lymphoblastic leukemia.
Tiensiwakul P
Cancer Genet Cytogenet; 2004 Feb; 149(1):85-8. PubMed ID: 15104290
[TBL] [Abstract][Full Text] [Related]
33. Translocation t(12;21) is related to in vitro cellular drug sensitivity to doxorubicin and etoposide in childhood acute lymphoblastic leukemia.
Frost BM; Forestier E; Gustafsson G; Nygren P; Hellebostad M; Jonsson OG; Kanerva J; Schmiegelow K; Larsson R; Lönnerholm G
Blood; 2004 Oct; 104(8):2452-7. PubMed ID: 15217836
[TBL] [Abstract][Full Text] [Related]
34. [Relation between TEL-AML1 expression level and clinical characteristics as well as early response to treatment in children with acute lymphoblastic leukemia].
Li ZG; Zhao W; Gao Z; Wu MY; Zhang YH; Shi HW; Xie J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):523-7. PubMed ID: 17605858
[TBL] [Abstract][Full Text] [Related]
35. TEL-AML1, expressed from t(12;21) in human acute lymphocytic leukemia, induces acute leukemia in mice.
Bernardin F; Yang Y; Cleaves R; Zahurak M; Cheng L; Civin CI; Friedman AD
Cancer Res; 2002 Jul; 62(14):3904-8. PubMed ID: 12124316
[TBL] [Abstract][Full Text] [Related]
36. Expression differences in TEL-AML1 fusion gene in leukemia glucocorticoid-sensitive and -resistant cell lines.
Wang XW; Xu YH
Genet Mol Res; 2015 Jul; 14(3):7883-93. PubMed ID: 26214469
[TBL] [Abstract][Full Text] [Related]
37. Acute lymphoblastic leukemia with TEL-AML1 fusion has lower expression of genes involved in purine metabolism and lower de novo purine synthesis.
Zaza G; Yang W; Kager L; Cheok M; Downing J; Pui CH; Cheng C; Relling MV; Evans WE
Blood; 2004 Sep; 104(5):1435-41. PubMed ID: 15142881
[TBL] [Abstract][Full Text] [Related]
38. Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice.
Tsuzuki S; Seto M; Greaves M; Enver T
Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8443-8. PubMed ID: 15155899
[TBL] [Abstract][Full Text] [Related]
39. TEL-AML1 preleukemic activity requires the DNA binding domain of AML1 and the dimerization and corepressor binding domains of TEL.
Morrow M; Samanta A; Kioussis D; Brady HJ; Williams O
Oncogene; 2007 Jun; 26(30):4404-14. PubMed ID: 17237815
[TBL] [Abstract][Full Text] [Related]
40. Interphase FISH on TEL/AML1 positive acute lymphoblastic leukemia relapses--analysis of clinical relevance of additional TEL and AML1 copy number changes.
Peter A; Heiden T; Taube T; Körner G; Seeger K
Eur J Haematol; 2009 Nov; 83(5):420-32. PubMed ID: 19594616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
